346 related articles for article (PubMed ID: 21297102)
1. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV
J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102
[TBL] [Abstract][Full Text] [Related]
2. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids.
Herrmann R; Fayad W; Schwarz S; Berndtsson M; Linder S
J Biomol Screen; 2008 Jan; 13(1):1-8. PubMed ID: 18040052
[TBL] [Abstract][Full Text] [Related]
3. A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516.
Arai K; Eguchi T; Rahman MM; Sakamoto R; Masuda N; Nakatsura T; Calderwood SK; Kozaki K; Itoh M
PLoS One; 2016; 11(9):e0162394. PubMed ID: 27622654
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness.
Hirano T; Satow R; Kato A; Tamura M; Murayama Y; Saya H; Kojima H; Nagano T; Okabe T; Fukami K
Biochem Pharmacol; 2013 Nov; 86(10):1419-29. PubMed ID: 24035834
[TBL] [Abstract][Full Text] [Related]
5. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
6. Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo.
Kokkinos MI; Wafai R; Wong MK; Newgreen DF; Thompson EW; Waltham M
Cells Tissues Organs; 2007; 185(1-3):191-203. PubMed ID: 17587825
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
8. 15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cells.
Lehtinen L; Vainio P; Wikman H; Reemts J; Hilvo M; Issa R; Pollari S; Brandt B; Oresic M; Pantel K; Kallioniemi O; Iljin K
J Pathol; 2012 Mar; 226(4):674-86. PubMed ID: 22072156
[TBL] [Abstract][Full Text] [Related]
9. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening identifies cardiac glycosides as potent inhibitors of human tissue kallikrein expression: implications for cancer therapies.
Prassas I; Paliouras M; Datti A; Diamandis EP
Clin Cancer Res; 2008 Sep; 14(18):5778-84. PubMed ID: 18794087
[TBL] [Abstract][Full Text] [Related]
11. A more aggressive breast cancer spheroid model coupled to an electronic capillary sensor system for a high-content screening of cytotoxic agents in cancer therapy: 3-dimensional in vitro tumor spheroids as a screening model.
Bartholomä P; Impidjati ; Reininger-Mack A; Zhang Z; Thielecke H; Robitzki A
J Biomol Screen; 2005 Oct; 10(7):705-14. PubMed ID: 16131482
[TBL] [Abstract][Full Text] [Related]
12. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart LA; Freyer JP; Hofstaedter F; Ebner R
J Biomol Screen; 2004 Jun; 9(4):273-85. PubMed ID: 15191644
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.
Lou Y; Preobrazhenska O; auf dem Keller U; Sutcliffe M; Barclay L; McDonald PC; Roskelley C; Overall CM; Dedhar S
Dev Dyn; 2008 Oct; 237(10):2755-68. PubMed ID: 18773493
[TBL] [Abstract][Full Text] [Related]
15. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L
Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening of a small molecule library for promoters and inhibitors of mesenchymal stem cell osteogenic differentiation.
Brey DM; Motlekar NA; Diamond SL; Mauck RL; Garino JP; Burdick JA
Biotechnol Bioeng; 2011 Jan; 108(1):163-74. PubMed ID: 20824673
[TBL] [Abstract][Full Text] [Related]
17. Diversity of cell-mediated adhesions in breast cancer spheroids.
Ivascu A; Kubbies M
Int J Oncol; 2007 Dec; 31(6):1403-13. PubMed ID: 17982667
[TBL] [Abstract][Full Text] [Related]
18. Drug effects analysis on cells using a high throughput microfluidic chip.
Gong Z; Zhao H; Zhang T; Nie F; Pathak P; Cui K; Wang Z; Wong S; Que L
Biomed Microdevices; 2011 Feb; 13(1):215-9. PubMed ID: 20978852
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line.
Deezagi A; Safari N
Mol Biol Rep; 2020 Nov; 47(11):8727-8737. PubMed ID: 33085048
[TBL] [Abstract][Full Text] [Related]
20. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]